Español
PDFs by language
Our 24/7 cancer helpline provides information and answers for people dealing with cancer. We can connect you with trained cancer information specialists who will answer questions about a cancer diagnosis and provide guidance and a compassionate ear.
Our highly trained specialists are available 24/7 via phone and on weekdays can assist through online chat. We connect patients, caregivers, and family members with essential services and resources at every step of their cancer journey. Ask us how you can get involved and support the fight against cancer. Some of the topics we can assist with include:
For medical questions, we encourage you to review our information with your doctor.
It can be hard to diagnose multiple myeloma early, and there are no recommended screening tests to look for it in most people.
Often, multiple myeloma causes no symptoms until it reaches an advanced stage. Sometimes, it causes vague symptoms that might at first seem to be caused by other diseases.
Multiple myeloma is sometimes found early when a routine blood test shows a high amount of protein in the blood, but there are no recommended screening tests to look for multiple myeloma in most people. (Screening is the use of tests or exams to find a disease in people who don’t have symptoms.)
MGUS (monoclonal gammopathy of unknown significance) and solitary plasmacytoma are conditions that might develop into multiple myeloma. Because people with these conditions are at higher risk of multiple myeloma, doctors usually do regular bloodwork to watch for early signs. This might lead to multiple myeloma being diagnosed earlier in people with MGUS or a solitary plasmacytoma.
For more on how multiple myeloma is diagnosed, see Tests for Multiple Myeloma.
Developed by the American Cancer Society medical and editorial content team with medical review and contribution by the American Society of Clinical Oncology (ASCO).
Kristinsson SY. Clinical course and management of monoclonal gammopathy of undetermined significance. UpToDate. 2024. Accessed at https://www.uptodate.com/contents/clinical-course-and-management-of-monoclonal-gammopathy-of-undetermined-significance on January 9, 2025.
Laubach JP. Multiple myeloma: Clinical features, laboratory manifestations, and diagnosis. UpToDate. 2024. Accessed at https://www.uptodate.com/contents/multiple-myeloma-clinical-features-laboratory-manifestations-and-diagnosis on January 7, 2025.
Rajkumar SV, Dispenzieri A. Chapter 101: Multiple myeloma and related disorders. In: Niederhuber JE, Armitage JO, Doroshow JH, Kastan MB, Tepper JE. Abeloff’s Clinical Oncology. 6th edition. Philadelphia, PA. Elsevier: 2020.
Last Revised: February 28, 2025
American Cancer Society medical information is copyrighted material. For reprint requests, please see our Content Usage Policy.
Sign up to stay up-to-date with news, valuable information, and ways to get involved with the American Cancer Society.